Abstract
Background and purpose
Cerebral angiography (CA) is the gold standard for moyamoya disease (MMD) staging and diagnosis, but CA findings are not well correlated with clinical symptoms. The purpose of this study was to establish novel cerebral-perfusion-based staging for MMD that is well correlated with clinical symptoms.
Materials and methods
From 2010 to 2015, regional cerebrovascular reserve (rCVR) was examined by single-photon emission computed tomography (SPECT) using NeuroGam® (Segamicorp, Houston, TX, USA) in 30 patients (17 women, 13 men; 60 hemispheres; mean 42.0 years old [range 5–60 years old]) with MMD, which was diagnosed by CA and magnetic resonance angiography (MRA). Brain CT or brain magnetic resonance imaging (MRI) was used to evaluate neurological conditions such as transient ischemic attack (TIA), cerebral hemorrhage, and cerebral infarction. A novel staging system for MMD was developed by combining findings from CA, MRI, and SPECT with NeuroGam®.
Results
Our novel staging system was strongly associated with clinical symptoms. Twenty-two hemispheres out of 60 were categorized as stage I, 24 hemispheres were categorized as stage II, and 14 hemispheres were categorized as stage III. Hemispheres with higher scores exhibited a higher incidence of clinical symptoms. These findings indicate that cerebral-perfusion-based staging is predictive of MMD clinical symptoms.
Conclusion
Perfusion-based SPECT staging correlates well with clinical symptoms and may be a reliable alternative to the Suzuki staging by CA.
Similar content being viewed by others
Abbreviations
- CA:
-
Cerebral angiography
- CBF:
-
Cerebral blood flow
- CVR:
-
Cerebrovascular reserve
- MMD:
-
Moyamoya disease
- MRA:
-
Magnetic resonance angiography
- MRI:
-
Magnetic resonance imaging
- rCBF:
-
Regional cerebral blood flow
- rCVR:
-
Regional cerebrovascular reserve
- SPECT:
-
Single-photon emission computed tomography
References
Takeuchi S, Kobayashi K, Tsuchida T, Imamura H, Tanaka R, Ito J (1982) Computed tomography in moyamoya disease. J Comput Assist Tomogr 6:24–32
Takahashi M, Miyauchi T, Kowada M (1980) Computed tomography of Moyamoya disease: demonstration of occluded arteries and collateral vessels as important diagnostic signs. Radiology 134:671–676
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240
Fukui M (1997) Current state of study on moyamoya disease in Japan. Surg Neurol 47:138–143
Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK (2009) Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus 26:E5
Suzuki J, Kodama N (1983) Moyamoya disease--a review. Stroke; a J Cerebral Cir 14:104–109
Saito N, Nakagawara J, Nakamura H, Teramoto A (2004) Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 18:323–331
So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, Kang E, Lee DS (2005) Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke; J Cerebral Circulation 36:1485–1489
Yamada I, Suzuki S, Matsushima Y (1995) Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 196:211–218
Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20:347–354
Suzuki J, Kodama N (1971) Cerebrovascular “Moyamoya” disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 22:223–236
Song YS, Oh SW, Kim YK, Kim SK, Wang KC, Lee DS (2012) Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT. Ann Nucl Med 26:47–57
Houkin K, Aoki T, Takahashi A, Abe H (1994) Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke; a Journal of Cerebral Cir 25:2159–2164
Kaufmann TJ, Huston J 3rd, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF (2007) Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 243:812–819
Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W (2003) Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 227:522–528
Honda M, Ezaki Y, Kitagawa N, Tsutsumi K, Ogawa Y, Nagata I (2006) Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol 66:155–159, discussion 159
Kuhn FP, Warnock G, Schweingruber T, Sommerauer M, Buck A, Khan N (2015) Quantitative H2[(15)O]-PET in pediatric moyamoya disease: evaluating perfusion before and after cerebral revascularization. J Stroke Cerebrovasc Dis: Off J Nat Stroke Assoc 24:965–971
Togao O, Mihara F, Yoshiura T, Tanaka A, Noguchi T, Kuwabara Y, Kaneko K, Matsushima T, Honda H (2006) Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR A J Neuroradiol 27:391–397
Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H (2001) Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke; J Cereb Cir 32:2110–2116
Horowitz M, Yonas H, Albright AL (1995) Evaluation of cerebral blood flow and hemodynamic reserve in symptomatic moyamoya disease using stable Xenon-CT blood flow. Surg Neurol 44:251–261, discussion 262
McAuley DJ, Poskitt K, Steinbok P (2004) Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. Neurosurgery 55:327–332, discussion 332-323
Webster MW, Makaroun MS, Steed DL, Smith HA, Johnson DW, Yonas H (1995) Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 21:338–344, discussion 344-335
Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, Matsushima Y, Ohno K (2006) Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography. J Cerebral Blood Flow Metabol : Off J Int Soc Cerebral Blood Flow and Metabol 26:291–300
Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian DG, Connelly A (2001) MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke; J Cerebral Cir 32:2810–2816
Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Matsushima T, Fukui M (1997) Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke; J Cerebral Circ 28:701–707
Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M (1994) Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81:843–850
Kanno I, Uemura K, Higano S, Murakami M, Iida H, Miura S, Shishido F, Inugami A, Sayama I (1988) Oxygen extraction fraction at maximally vasodilated tissue in the ischemic brain estimated from the regional CO2 responsiveness measured by positron emission tomography. J Cerebral Blood Flow Metab : Off J Internat Soc Cerebral Blood Flow and Metab 8:227–235
Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, Ohno K (2005) Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 76:663–669
Nariai T, Senda M, Ishii K, Wakabayashi S, Yokota T, Toyama H, Matsushima Y, Hirakawa K (1998) Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study. Stroke; J Cerebral Circ 29:1281–1292
Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ (1998) Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. Jama 280:1055–1060
Marushima A, Tsurushima H, Suzuki K, Nakai Y, Nemoto H, Matsumura A (2011) Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease. World Neurosurg 76:304–310
Hoshi H, Ohnishi T, Jinnouchi S, Futami S, Nagamachi S, Kodama T, Watanabe K, Ueda T, Wakisaka S (1994) Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nuclear Med : Off Publ Soc Nuclear Med 35:44–50
Lee SK, Kim DI, Jeong EK, Kim SY, Kim SH, In YK, Kim DS, Choi JU (2003) Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 24:741–747
Nagasawa N, Yamakado K, Yamada T, Nakanishi S, Ito M, Suzawa N, Kitano T, Takeda K (2009) Three-dimensional stereotactic ROI template for measuring regional cerebral blood flow in 99mTc-ECD SPECT: comparison with the manual tracing method. Nucl Med Commun 30:155–159
Takeuchi R, Matsuda H, Yonekura Y, Sakahara H, Konishi J (1997) Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L, L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method. J Cerebral Blood Flow Metab : Off J Int Soc Cerebral Blood Flow Metab 17:1020–1032
Touho H, Karasawa J, Ohnishi H (1996) Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke; J Cerebral Circ 27:282–289
Hill TC, Holman BL, Lovett R, O’Leary DH, Front D, Magistretti P, Zimmerman RE, Moore S, Clouse ME, Wu JL, Lin TH, Baldwin RM (1982) Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication. J Nuclear Med : Off Publication, Soc Nucl Med 23:191–195
Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, Wu JL, Lin TH, Phelps ME (1982) Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med : Off Publication, Soc Nucl Med 23:196–203
Lee RG, Hill TC, Holman BL, Royal HD, O’Leary DH, Clouse ME (1984) Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke. J Neurosurg 61:449–452
Magistretti P, Uren R, Blume H, Schomer D, Royal H (1982) Delineation of epileptic focus by single photon emission tomography. Eur J Nucl Med 7:484–485
Holman BL, Hill TC, Polak JF, Lee RG, Royal HD, O’Leary DH (1984) Cerebral perfusion imaging with iodine 123-labeled amines. Arch Neurol 41:1060–1063
Defer G, Moretti JL, Cesaro P, Sergent A, Raynaud C, Degos JD (1987) Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery. Arch Neurol 44:715–718
Heyn C, Poublanc J, Crawley A, Mandell D, Han JS, Tymianski M, terBrugge K, Fisher JA, Mikulis DJ (2010) Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease. AJNR Am J Neuroradiol 31:862–867
Acknowledgments
This work was supported by the National Research Foundation of Korea (2010-0023851, 2012-042282, and NRF-2013R1A2A2A01067990).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest statement
The authors have no conflict of interest.
Grant support
National Research Foundation of Korea (2010-0023851, 2012-042282, and NRF-2013R1A2A2A01067990).
Rights and permissions
About this article
Cite this article
Han, JH., Park, Y.S., Lee, W.H. et al. Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease. Childs Nerv Syst 32, 1471–1477 (2016). https://doi.org/10.1007/s00381-015-2974-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2974-1